A Computer Simulation Model For The Evaluation Of Interventions For The Management Of Type 2 Diabetes In Austral
Funder
National Health and Medical Research Council
Funding Amount
$334,505.00
Summary
Diabetes imposes a heavy personal, societal and financial burden in Australia and this is predicted to increase over time. It has been estimated that one million people in Australia have diabetes and the annual cost of diabetes care is in the order of 3 billion dollars. Many studies show that the current quality of diabetes care in Australia is sub-optimal and therefore decisions must be made about prioritizing the allocation of limited resources to correct these deficiencies. This project invol ....Diabetes imposes a heavy personal, societal and financial burden in Australia and this is predicted to increase over time. It has been estimated that one million people in Australia have diabetes and the annual cost of diabetes care is in the order of 3 billion dollars. Many studies show that the current quality of diabetes care in Australia is sub-optimal and therefore decisions must be made about prioritizing the allocation of limited resources to correct these deficiencies. This project involves building a computer simulation model to inform clinicians and assist policy makers in the efficient allocation of resources to improve the quality of diabetes care in Australia.Read moreRead less
Use Of Expression Profiling To Identify Genes Influencing Cardiovascular Risk In The Norfolk Island Population Isolate
Funder
National Health and Medical Research Council
Funding Amount
$697,409.00
Summary
This study will use a unique population isolate from Norfolk Island. We aim to identify genes that play a role in cardiovascular disease risk. Norfolk has a population of ~1200 permanent residents, most of whom are direct descendents of 18th century English Bounty mutineers and Polynesian women. We will undertake gene expression mapping to identify genomic loci that influence cardiovascular disease using samples from this population isolate.
Fine Scale Mapping And Identification Of The IBD1 Gene On Chromsosome 16
Funder
National Health and Medical Research Council
Funding Amount
$483,849.00
Summary
One of the greatest challenges facing contemporary gastroenterology is to understand the causes of the inflammatory bowel diseases (IBD). Studies on the prevalence, incidence and cost of IBD indicate that these diseases have considerable impact in Australia. On average, patients lose more than 13 days from work each year, and in hospital, IBD in-patients accounted for 7% of total admissions and 10% of total bed days at an average cost of $2600 per admission. We estimate that there may be more th ....One of the greatest challenges facing contemporary gastroenterology is to understand the causes of the inflammatory bowel diseases (IBD). Studies on the prevalence, incidence and cost of IBD indicate that these diseases have considerable impact in Australia. On average, patients lose more than 13 days from work each year, and in hospital, IBD in-patients accounted for 7% of total admissions and 10% of total bed days at an average cost of $2600 per admission. We estimate that there may be more than 10,000 Australians who suffer from IBD. The existence of a genetic predisposition to IBD is now well established, and there is strong evidence that the disease is complex, resulting from the interaction of a number of different genes. To date, one genetic localisation on chromosome 16 has been established in several different populations, and we have confirmed the importance of this localisation in the Australian population. We will further refine the localisation by fine scale mapping in the pericentromeric region of chromosome 16 by identifying and studying the inheritance of novel markers in the region. We will then identify and characterise the gene itself using several complementary appoaches that rely on differences at the molecular level between disease and normal tissue. This work is part of the international effort to identify all IBD susceptibility genes. Once that is achieved, approaches to explaining the interactions between the genes, their protein products and environmental triggers can be determined. Only when the mechanisms of these interactions are understood will the expectation of rational therapies based on an understanding of disease aetiology be possible.Read moreRead less